Imagenetix Inc IAGX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.01
- Market Cap
- $28.42
- Volume/Avg
- 5,000 / 5,000
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Imagenetix Inc is engaged in developing, formulating licensing and selling over-the-counter, natural-based nutritional supplements. Its products include Celadrin, a product formulation for joint health; and Periodyne a periodontal product. These products are offered through multiple channels of distribution, including direct marketing companies, also known as network marketing or multi-level marketing companies and chain store retailers. Geographically all the business activities are functioned primarily through the United States.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 5
- Website
- —
Valuation
|
Metric
|
IAGX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
IAGX
|
|---|---|
Quick Ratio | 0.48 |
Current Ratio | 0.69 |
Interest Coverage | −6.25 |
Quick Ratio
IAGX
Profitability
|
Metric
|
IAGX
|
|---|---|
Return on Assets (Normalized) | −94.92% |
Return on Equity (Normalized) | −541.72% |
Return on Invested Capital (Normalized) | −219.94% |
Return on Assets
No chart available
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Wngxryqg | Ncvb | $82.5 Bil | |||
| Merck KGaA ADR
MKKGY
| Rlzknxmvb | Qqgybc | $73.2 Bil | |||
| Haleon PLC ADR
HLN
| Vqyrzbv | Sftn | $41.0 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Gjqpjpk | Pmnmh | $19.2 Bil | |||
| Viatris Inc
VTRS
| Qltmlcwx | Wwxrx | $14.0 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Kbqshvjfd | Yxw | $13.7 Bil | |||
| Catalent Inc
CTLT
| Xjrvmfr | Glntxf | $10.6 Bil | |||
| Perrigo Co PLC
PRGO
| Rzkjbtl | Hrrf | $3.8 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Kftvmvr | Mdmnhv | $3.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Tgjhrhgyj | Nmkxx | $3.0 Bil |